Table 3.
Small GTPase | Related disease | Pathway/mechanism | References |
---|---|---|---|
Rac3 | A novel neurodevelopmental syndrome | De novo monoallelic missense variants in Rac3, including one recurrent change | Costain et al., 2019 |
RhoA | Diabetic Parkinson’s disease or dementia | Accelerated neuron loss via the 5-hydroxytryptamine 2 receptor | Zimering, 2018 |
Cdc42 | Epileptic-seizures | Regulating synaptic inhibition | Zhang Y. et al., 2015 |
Rac1 | Fragile X syndrome | Rac1 is necessary for normal spine development and long-term synaptic plasticity | Bongmba et al., 2011 |
Rac1 | Epilepsy | Patients suffering from temporal lobe epilepsy (TLE) and experimental epileptic rats | Li et al., 2016 |
RhoB | Glioblastoma | Cytokine-induced STAT3 activation, activated p53 and p21 | Ma et al., 2015 |
Rac1 and Cdc42 | Developmental delay, secondary macrocephaly, seizures, and ataxic gait | De novo PAK1 mutations c.392A>G (p.Tyr131Cys) and c.1286A>G (p.Tyr429Cys) | Harms et al., 2018 |
Rac1 | Drug withdrawal | Rac1-dependent GABAAR endocytosis, synaptic plasticity as well as learning and memory | Wang et al., 2017 |
Rac1 | Alcohol use disorders | Rac1/Arfaptin/Arf6 pathway | Peru Y Colón de Portugal et al., 2012 |
RhoA | Cocaine | Phosphorylated ERM levels and synaptic changes in the NAcc | Kim et al., 2009 |
Rab7 | Parkinson’s disease | Clearance of α-synuclein aggregates | Saridaki et al., 2018 |
Rab11 | Parkinson’s disease | Reduces α-synuclein aggregation and toxicity | Chutna et al., 2014 |
Rab39b | Parkinson’s disease | Reduce steady-state levels of α-synuclein | Wilson et al., 2014 |
Rab | Infantile encephalopathy | Rab GTPase-Activating Protein dysregulates mTOR signaling | Chong et al., 2016 |
Rab1A | Alzheimer’s disease | Mediates Golgi dynamics | Mohamed et al., 2017 |
Rab3A | Alzheimer’s disease | Localizes in presynaptic vesicles and regulates exocytosis | Udayar et al., 2013 |
Rab4 | Alzheimer’s disease | Regulates endosomal recycling | Ginsberg et al., 2011 |
Rab5 | Alzheimer’s disease | Modulates endosomal membrane trafficking, sorting and endosomal fusion | Ginsberg et al., 2010a,b |
Rab6 | Alzheimer’s disease | Regulates retrograde Golgi-ER trafficking | Scheper et al., 2007 |
Rab7A | Alzheimer’s disease | Controls transport to late endosomes and lysosomes/regulates tau secretion | Ginsberg et al., 2011; Rodriguez et al., 2017; Zafar et al., 2017 |
Rab8 | Alzheimer’s disease | Modulates polarized trafficking | Shimohama et al., 1999; Kametani et al., 2004; Li et al., 2012 |
Rab10 | Alzheimer’s disease | pRab10-T73, decrease in Aβ42 and Aβ42/Aβ40 ratio | Ridge et al., 2017; Yan et al., 2018 |
Rab11A/Rab11B | Alzheimer’s disease | Regulates both endocytic and exocytic trafficking pathways | Udayar et al., 2013; Buggia-Prevot et al., 2014; Xu et al., 2015; Zhao et al., 2015 |
Rab14 | Alzheimer’s disease | Endocytic recycling and Golgi-endosome trafficking | Linford et al., 2012; Prekeris, 2012 |
Rab17 | Alzheimer’s disease | Involved in phagocytic removal of apoptotic cells | Udayar et al., 2013 |
Rab24 | Alzheimer’s disease | Involved in autophagy | Ginsberg et al., 2010a |
Rab27 | Alzheimer’s disease | Regulates exocytosis, endocytosis and phagocytosis | Ginsberg et al., 2011 |
Rab36 | Alzheimer’s disease | Involved in late endosome and lysosome distribution | Udayar et al., 2013 |
Rab3a | Glioma | Increases cyclin D1 expression | Kim et al., 2014 |
Rab38 | Glioblastomas | Whole genome mRNA expression microarray data on 220 glioma samples from the Chinese glioma genome atlas | Wang and Jiang, 2013 |
Rab28 | Cone-rod dystrophy | Retinal dystrophies | Roosing et al., 2013 |
Arf1 | Creutzfeldt-Jakob disease | Arf/Rho/MLC signaling | Zafar et al., 2015 |
Arl2 and Arl3 | Retina disease | Participate in the trafficking of lipidated membrane-associated proteins and colocalize in the inner segment with UNC119A and PDEδ | Veltel et al., 2008a; Zhang H. et al., 2015; Hanke-Gogokhia et al., 2016a,b; Moshiri et al., 2017 |
Arf6 | Alcohol use disorders | Rac1/Arfaptin/Arf6 pathway | Peru Y Colón de Portugal et al., 2012 |
Arl6 | Diabetic retinopathy | Regulates VEGFR2 trafficking and signal transduction | Zhu et al., 2017 |
Arl6 | ALS | Potential driver pathophysiological events involving endoplasmic reticulum stress and autophagy | Zhai et al., 2015 |
Arf72A | Retina disease | Rescues the ninaE(D1)-related membrane accumulation and suppresses ninaE(D1)-triggered retinal degeneration | Lee et al., 2011 |
Arl2 | Bardet–Biedl syndrome type 3 | Disrupt a threonine residue important for GTP binding and function of several related small GTP-binding proteins | Fan et al., 2004 |
Ran | Frontotemporal dementia | Regulates nuclear import via TDP-43 pathway | Ward et al., 2014 |
Ran | Alzheimer’s disease | Transcription regulators in the nucleus | Mastroeni et al., 2013 |
Ran | Glioblastoma multiforme | The Survivin-Ran complex | Guvenc et al., 2013 |
ALS, amyotrophic lateral sclerosis.